These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 7653432)

  • 1. Prokinetic therapy for gastroesophageal reflux disease.
    Robinson M
    Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents.
    McCallum RW
    Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prokinetic agents: a key in the future of gastroenterology.
    Reynolds JC
    Gastroenterol Clin North Am; 1989 Jun; 18(2):437-57. PubMed ID: 2668178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current status of gastric prokinetic drugs.
    Schapira M; Henrion J; Heller FR
    Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prokinetic drugs in digestive disorders].
    Carella G; Marra L
    Clin Ter; 1993 Sep; 143(3):219-24. PubMed ID: 8222553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease.
    Arabehety JT; Leitão OR; Fassler S; Olarte M; Serrano C
    Clin Ther; 1988; 10(4):421-8. PubMed ID: 3079010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B; Greving I
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prokinetic therapy in gastroesophageal reflux disease.
    Champion MC
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():55B-65B. PubMed ID: 9347180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cisapride efficacy in gastroesophageal reflux in children].
    Bottaro G; Rotolo N; Spina M; Azzaro F; Galletta C; Romano D; Castiglione N; Patanè R
    Pediatr Med Chir; 1993; 15(2):141-4. PubMed ID: 8321715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prokinetic drug therapy in children: a review of current options.
    Chicella MF; Batres LA; Heesters MS; Dice JE
    Ann Pharmacother; 2005 Apr; 39(4):706-11. PubMed ID: 15755792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical considerations in GERD (gastroesophageal reflux disease) therapy: focus on cisapride.
    Snape WJ
    Am J Manag Care; 1997 May; 3(5):766-71. PubMed ID: 10184748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prokinetic agents in postgastrectomy patients.
    Patterson DJ
    Gastroenterol Clin North Am; 1994 Jun; 23(2):313-25. PubMed ID: 7915253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domperidone, metoclopramide, and placebo. All give symptomatic improvement in gastroesophageal reflux.
    Maddern GJ; Kiroff GK; Leppard PI; Jamieson GG
    J Clin Gastroenterol; 1986 Apr; 8(2):135-40. PubMed ID: 3745846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease.
    Ramirez B; Richter JE
    Aliment Pharmacol Ther; 1993 Feb; 7(1):5-20. PubMed ID: 8094981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ
    J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the current status of prokinetic agents in gastroenterology.
    McCallum RW
    Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastroesophageal reflux and prokinetic agents.
    Hammer D
    Neonatal Netw; 2005; 24(2):51-8; quiz 59-62. PubMed ID: 15835479
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
    Brown CK; Khanderia U
    Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prokinetics in reflux disease. Action mechanisms and clinical effects].
    Hatlebakk JG; Berstad A
    Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy of reflux oesophagitis: an update.
    Tytgat GN
    Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.